Methods for treating inflammation-mediated conditions of the eye

Details for Australian Patent Application No. 2001273166 (hide)

Owner Allergan, Inc.

Inventors Hu, Mae W. L.; Wong, Vernon G

Agent FB Rice

Pub. Number AU-B-2001273166

PCT Pub. Number WO02/02076

Priority 60216236 05.07.00 US; 09693008 20.10.00 US

Filing date 3 July 2001

Wipo publication date 14 January 2002

Acceptance publication date 27 October 2005

International Classifications

A61K 009/00 Medicinal preparations characterised by special physical form

A61K 047/34 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

26 February 2004 Assignment before Grant

  Oculex Pharmaceuticals, Inc. The application has been assigned to Allergan, Inc.

27 October 2005 Application Accepted

  Published as AU-B-2001273166

23 February 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001273167

2001273165-Sterilization indicator